This page shows the latest Adcentris news and features for those working in and with pharma, biotech and healthcare.
We are excited about the approval of Adcentris for children and adolescents with high risk cHL because this medicine, which has become part of standard of care for adults with previously
Becomes the first new treatment for advanced Hl in more than 40 years
Data shows the drug improves PFS and symptom burden in CTCL patients
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
No results were found
Accession was a born from a passion and a vision. A passion to harness the power of market access to...